NASDAQ: GOSSGossamer Bio Inc Stock Ownership - Who owns Gossamer Bio?
Insider buying vs selling
Have Gossamer Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Richard Aranda | Chief Medical Officer | 2024-06-24 | 1,908 | $0.66 | $1.26kSell |
| Faheem Hasnain | President CEO | 2024-06-21 | 372,000 | $0.67 | $250.36kBuy |
| Bryan Giraudo | COOCFO | 2024-06-18 | 100,000 | $0.59 | $59.10kBuy |
| Robert Paul Smith Jr. | Chief Commercial Officer | 2024-06-17 | 25,000 | $0.60 | $15.05kBuy |
GOSS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GOSS insiders and whales buy or sell their stock.
GOSS Shareholders
What type of owners hold Gossamer Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Octagon Capital Advisors LP | 8.07% | 18,350,000 | $22.75M | Institution |
| Nea Management Company LLC | 7.96% | 18,093,034 | $22.44M | Institution |
| Omega Fund V LP | 5.94% | 13,506,832 | $16.75M | Insider |
| Vanguard Group Inc | 4.44% | 10,083,881 | $12.50M | Institution |
| Arch Venture Management LLC | 3.54% | 8,055,916 | $9.99M | Institution |
| Fmr LLC | 3.34% | 7,592,980 | $9.42M | Institution |
| Acadian Asset Management LLC | 2.80% | 6,358,113 | $7.88M | Institution |
| Silverarc Capital Management LLC | 2.78% | 6,320,684 | $7.84M | Institution |
| Palo Alto Investors LP | 2.76% | 6,276,893 | $7.78M | Institution |
| Samsara Biocapital LLC | 2.70% | 6,130,268 | $7.60M | Institution |
GOSS vs Biotech Stocks
Gossamer Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.